Morgan Stanley Opens 15-Day Research Tactical Idea on Monsanto

Morgan Stanley has opened a research tactical idea on Monsanto Company

believing the share price will rise over the next 15 days. In the report, Morgan Stanley writes, "We believe that MON's ~4% underperformance vs. the S&P 500 in the ~50 days will likely reverse as F2Q12 results and outlook come in ahead of consensus. A tight US corn seed market has likely had several positive impacts including a lack of price competition, Refuge Reduction family penetration at least at high end of guidance, and a likely greater incremental market share on US planted corn acreage above ~92 million acres." Morgan Stanley maintains its Overweight rating on Monsanto Company, which is currently trading up $1.29 from Friday's $78.44 closing price.